LOADING
Comparing Merck & Company (MRK) and Rivian Automotive (RIVN) across the Health Care and Consumer Discretionary sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | RIVN |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $356.0B | $21.4B |
| P/E Ratio | 116.4 | -- |
| Forward P/E | 15.3 | -- |
| PEG Ratio | 2.71 | -- |
| EPS | $1.24 | $-2.59 |
| Revenue Growth (YoY) | 5.1% | 27.2% |
| Profit Margin | 4.8% | -55.0% |
| Return on Equity | 7.0% | -57.5% |
| Dividend Yield | 2.31% | -- |
| Beta | 0.23 | 1.62 |
| 52-Week High | $156.00 | $22.69 |
| 52-Week Low | $79.67 | $12.39 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.